Latest news
AstraZeneca (LSE:AZN) Signs Global Precision Oncology Diagnostics Alliance - simplywall.stsimplywall.st · Fri, 07 Aug 2026 13:51:01 GMTEvotec and Odyssey Therapeutics enter AI-enabled drug discovery collaboration in autoimmune and inflammatory diseases - The Pharma LetterThe Pharma Letter · Fri, 07 Aug 2026 10:18:54 GMTPathos AI Enters Two lIcensing Deals | PharmExec - Pharmaceutical ExecutivePharmaceutical Executive · Tue, 04 Aug 2026 19:07:22 GMTPathos AI Licenses Alphamab's TROP2/HER3 Bispecific ADC, JSKN016 - BioPharm InternationalBioPharm International · Tue, 04 Aug 2026 17:01:14 GMTMorrison Avenue Announces Opening of Hilltop Auburn, a New Class-A Student Housing Community Serving Auburn University - The Norfolk Daily NewsThe Norfolk Daily News · Tue, 04 Aug 2026 15:00:00 GMTM&A Roundup: Pathos AI Enter’s Licensing Agreements with AstraZeneca & Alphamab Oncology, Curium Enters Merger Agreement with Lantheus - Pharmaceutical ExecutivePharmaceutical Executive · Tue, 04 Aug 2026 14:07:34 GMTPathos AI Secures Global Rights to Alphamab's Experimental Breast Cancer Drug in Up to $1.5 Billion Deal - Voice of HealthcareVoice of Healthcare · Tue, 04 Aug 2026 13:55:12 GMTPathos AI strikes deals with Alphamab and AstraZeneca to build AI-native oncology pipeline - Manufacturing ChemistManufacturing Chemist · Tue, 04 Aug 2026 12:09:55 GMT